Evaluation of Pharmacokinetics, Safety and Tolerability of Single and Multiple Oral Doses of Neramexane Mesylate in Healthy Japanese Subjects.
Phase of Trial: Phase I
Latest Information Update: 14 Apr 2011
At a glance
- Drugs Neramexane (Primary)
- Indications Alzheimer's disease
- Focus Pharmacokinetics
- 14 Apr 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 22 Oct 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 17 Oct 2009 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.